Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Immunol., 10 October 2025

Sec. Cancer Immunity and Immunotherapy

Volume 16 - 2025 | https://doi.org/10.3389/fimmu.2025.1717357

Correction: Case Report: Prognostic evaluation of immunotherapy in two patients with SMARCA4-UT using TCR as a new marker

This article is a correction to:

  1. Case Report: Prognostic evaluation of immunotherapy in two patients with SMARCA4-UT using TCR as a new marker

    1. Read original article
Xiayu Wang&#x;Xiayu Wang1†Yiwei Zhou&#x;Yiwei Zhou2†Qijiao LiQijiao Li2Jun WangJun Wang1Yu QianYu Qian1Bing Yang*Bing Yang1*
  • 1Dept. of Thoracic Oncology, Hubei Cancer Hospital, Wuhan, China
  • 2Kindstar Global Precision Medicine Institute, Wuhan, China

A Correction on
Case Report: Prognostic evaluation of immunotherapy in two patients with SMARCA4-UT using TCR as a new marker

By Wang X, Zhou Y, Li Q, Wang J, Qian Y and Yang B (2025). Front. Immunol. 16:1618118. doi: 10.3389/fimmu.2025.1618118

A correction has been made to the author list. The “equal contributions symbol” was erroneously excluded from authors “Xiayu Wang and Yiwei Zhou”. The department for affiliation 2 has also been removed.

The corrected author list and affiliation appears below:

“Xiayu Wang ‡¹, Yiwei Zhou ‡², Qijiao Li², Jun Wang¹, Yu Qian¹, Bing Yang¹*

¹Dept. of Thoracic Oncology, Hubei Cancer Hospital, Wuhan, China

²Kindstar Global Precision Medicine Institute, Wuhan, China

‡These authors contributed equally to this work and share first authorship”.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: SMARCA4, TCR, lung cancer, non-small cell lung carcinoma, check-point inhibitors, TILs

Citation: Wang X, Zhou Y, Li Q, Wang J, Qian Y and Yang B (2025) Correction: Case Report: Prognostic evaluation of immunotherapy in two patients with SMARCA4-UT using TCR as a new marker. Front. Immunol. 16:1717357. doi: 10.3389/fimmu.2025.1717357

Received: 01 October 2025; Accepted: 02 October 2025;
Published: 10 October 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Lausanne, Switzerland

Copyright © 2025 Wang, Zhou, Li, Wang, Qian and Yang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Bing Yang, MjQ1NDYzMjM5QHFxLmNvbQ==

†These authors have contributed equally to this work and share first authorship

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.